Rallybio Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q2 2024 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q3 2024 | 3 | -$0.31 | -$0.26 | -$0.29 |
| Q1 2025 | 2 | -$0.31 | -$0.24 | -$0.28 |
| Q2 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q3 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q4 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
Rallybio Corporation Earnings Date And Information
Rallybio Corporation last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.26 earnings per share for the quarter, topping analysts' consensus estimates of $-0.35 by $0.09. The company had revenue of 299,000 for the quarter and had revenue of 0 for the year. Rallybio Corporation has generated $-2 earnings per share over the last year ($-1.84 diluted earnings per share) and currently has a price-to-earnings ratio of -0.68. Rallybio Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based on prior year's report dates.
Rallybio Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.35 | -$0.26 | 0.09 | $75,000 | $299,000 |
| 08/08/2024 | Q2 2024 | -$0.42 | -$0.37 | 0.05 | $166,667 | $299,000 |
| 05/09/2024 | Q1 2024 | -$0.50 | -$0.47 | 0.03 | $0 | |
| 03/12/2024 | Q4 2023 | -$0.44 | -$0.50 | -0.06 | $228,000 | |
| 11/09/2023 | Q3 2023 | -$0.51 | -$0.45 | 0.06 | $0 | |
| 08/08/2023 | Q2 2023 | -$0.48 | -$0.46 | 0.02 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.50 | -$0.39 | 0.11 | $0 | |
| 03/06/2023 | Q4 2022 | -$0.63 | -$0.43 | 0.2 | $0 | |
| 11/07/2022 | Q3 2022 | -$0.54 | -$0.58 | -0.04 | $0 | |
| 08/08/2022 | Q2 2022 | -$0.61 | -$0.57 | 0.04 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.48 | -$0.47 | 0.01 | $0 | |
| 03/15/2022 | Q4 2021 | -$0.39 | -$0.42 | -0.03 | $0 | |
| 11/10/2021 | Q3 2021 | -$0.89 | -$0.37 | 0.52 | $0 | |
| 09/09/2021 | Q2 2021 | -$2.80 | -$0.36 | 2.44 | $0 | |
| 03/30/2021 | Q1 2021 | -$0.60 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.47 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.32 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.22 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.17 | $0 |
Rallybio Corporation Earnings: Frequently Asked Questions
-
When is Rallybio Corporation's earnings date?
Rallybio Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based off last year's report dates.
-
Did Rallybio Corporation beat their earnings estimates last quarter?
In the previous quarter, Rallybio Corporation (:RLYB) reported $-0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.35 by $0.09.
-
How can I listen to Rallybio Corporation's earnings conference call?
The conference call for Rallybio Corporation's latest earnings report can be listened to online.
-
How can I read Rallybio Corporation's conference call transcript?
The conference call transcript for Rallybio Corporation's latest earnings report can be read online.
-
How much profit does Rallybio Corporation generate each year?
Rallybio Corporation (:RLYB) has a recorded net income of $0. Rallybio Corporation has generated $-1.84 earnings per share over the last four quarters.
-
What is Rallybio Corporation's price-to-earnings ratio?
Rallybio Corporation (:RLYB) has a price-to-earnings ratio of -0.68 and price/earnings-to-growth ratio is -0.06.
